alexa Abstract | Evaluation of antitumor activity of novel triazole derivatives

Der Pharmacia Sinica
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


In the present study, the three novel triazole derivatives (13c, 11b & 16c) were evaluated for their anti-tumor activity against Ehrlich Ascites Carcinoma (EAC) bearing Swiss albino mice. The test compounds were subjected for in-vitro preliminary cytotoxicity screening by trypan blue exclusion and MTT assay on cancer cell lines. In EAC ascites tumor model, the anti tumor activity of 13c, 11b and 16c was evaluated at the doses of 50mg/kg b.w by measuring the mean survival time, body weight changes, haematological parameters (WBC & RBC count and haemoglobin content) and cyclophosphamide was used as a standard. In addition, the effect of test compound on DNA was evaluated by DNA fragmentation assay. Among all the test compounds, 13c showed promising cytotoxic activity as compared to 11b and 16c when tested against cancer cell lines. In EAC model, the novel triazole compounds (13c, 11b and 16c) at a dose of 50mg/kg markedly enhanced the mean survival time of tumor bearing mice and activity was found more with compound 13c. The haematological parameters were also revealed anticancer activity of triazole derivatives whereas compound 13c has shown better activity when compared with other two compounds. In the mechanistic studies, the induction of apoptosis was confirmed by agarose gel electrophoresis and DNA binding studies revealed the binding efficacy of the compounds. From the present study it can be concluded that compound 13c has shown better anticancer activity when tested in-vitro and in-vivo than the 11b and 16c. However this study gives a lead for further research to establish the anticancer activity of these novel triazole derivatives.

To read the full article Peer-reviewed Article PDF image

Author(s): Bhavana V Praveen Singh Krishna KL and Purohit MN


anti-tumor, triazole derivatives, trypan blue exclusion assay, MTT assay, Pharmaceutics, Pharmaceutical Formulation and Analysis

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]om

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version